HALOPERIDOL
NDC 82619-105, haloperidol, tablet, from Creekwood Pharmaceuticals LLC.
- Product NDC
- 82619-105
- Status
- Listed
- Labeler
- Creekwood Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218162
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82619-105 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HALOPERIDOL.5 mg/1
Pharmacologic classes
Typical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82619-105-01 | 82619010501 | 100 TABLET in 1 BOTTLE (82619-105-01) |
| 82619-105-02 | 82619010502 | 1000 TABLET in 1 BOTTLE (82619-105-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9763c044-7430-48f7-bf3e-da1c7c683955
Use it
Look up 82619-105 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82619-105 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82619-105. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.